Bisphenol A as epigenetic modulator: Setting the stage for carcinogenesis?

European Journal of Clinical Investigation

Volumn 45, Issue s1, 2015, Pages 32-36

  Ferreira, Luciana L ^a,b   Couto, Renata ^a,b   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Bisphenol A; Cancer; Endocrine disrupting chemicals; Epigenetics; Epigenotoxicity

Indexed keywords

BENZHYDRYL COMPOUNDS; BISPHENOL A; ENDOCRINE DISRUPTORS; ESTROGENS, NON-STEROIDAL; PHENOLS;

CARCINOGENESIS; CHEMICALLY INDUCED; DRUG EFFECTS; EPIGENESIS, GENETIC; HUMANS;

BENZHYDRYL COMPOUNDS; CARCINOGENESIS; ENDOCRINE DISRUPTORS; EPIGENESIS, GENETIC; ESTROGENS, NON-STEROIDAL; HUMANS; PHENOLS;

EID: 84919363527     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12362     Document Type: Review

References (50)

1. Michalowicz J. Bisphenol A-sources, toxicity and biotransformation. Environ Toxicol Pharmacol 2014;37:738-58.
2. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011;127:204-15.
3. Mileva G, Baker S, Konkle A, Bielajew C. Bisphenol-A: epigenetic reprogramming and effects on reproduction and behavior. Int J Environ Res Public Health 2014;11:7537-61.
4. Fenichel P, Chevalier N, Brucker-Davis F. Bisphenol A: an endocrine and metabolic disruptor. Ann Endocrinol (Paris) 2013;74:211-20.
5. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011;127:27-34.
6. Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014;64:83-90.
7. Kamrin MA. Bisphenol A: a scientific evaluation. MedGenMed 2004;6:7.
8. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 2002;15:1281-7.
9. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2004;113:391-5.
10. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007;24:139-77.
11. Sheehan DM. Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: initial results confirmed. Proc Soc Exp Biol Med 2000;224:57-60.
12. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013;42:132-55.
13. Matsushima A, Teramoto T, Okada H, Liu X, Tokunaga T, Kakuta Y et al. ERRgamma tethers strongly bisphenol A and 4-alpha-cumylphenol in an induced-fit manner. Biochem Biophys Res Commun 2008;373:408-13.
14. Thomas P, Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 2006;102:175-9.
15. Sun H, Xu LC, Chen JF, Song L, Wang XR. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene. Food Chem Toxicol 2006;44:1916-21.
16. Luger K. Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev 2003;13:127-35.
17. Papamichos-Chronakis M, Peterson CL. Chromatin and the genome integrity network. Nat Rev Genet 2013;14:62-75.
18. Izzotti A, Kanitz S, D'Agostini F, Camoirano A, De Flora S. Formation of adducts by bisphenol A, an endocrine disruptor, in DNA in vitro and in liver and mammary tissue of mice. Mutat Res 2009;679:28-32.
19. Tsutsui T, Tamura Y, Yagi E, Hasegawa K, Takahashi M, Maizumi N et al. Bisphenol-A induces cellular transformation, aneuploidy and DNA adduct formation in cultured Syrian hamster embryo cells. Int J Cancer 1998;75:290-4.
20. De Flora S, Micale RT, La Maestra S, Izzotti A, D'Agostini F, Camoirano A et al. Upregulation of clusterin in prostate and DNA damage in spermatozoa from bisphenol A-treated rats and formation of DNA adducts in cultured human prostatic cells. Toxicol Sci 2011;122:45-51.
21. Cavalieri EL, Rogan EG. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol? IUBMB Life 2010;62:746-51.
22. Atkinson A, Roy D. In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). Biochem Biophys Res Commun 1995;210:424-33.
23. Iso T, Watanabe T, Iwamoto T, Shimamoto A, Furuichi Y. DNA damage caused by bisphenol A and estradiol through estrogenic activity. Biol Pharm Bull 2006;29:206-10.
24. Tiwari D, Vanage G. Mutagenic effect of Bisphenol A on adult rat male germ cells and their fertility. Reprod Toxicol 2013;40:60-8.
25. Hulak M, Gazo I, Shaliutina A, Linhartova P. In vitro effects of bisphenol A on the quality parameters, oxidative stress, DNA integrity and adenosine triphosphate content in sterlet (Acipenser ruthenus) spermatozoa. Comp Biochem Physiol C Toxicol Pharmacol 2013;158:64-71.
26. Allard P, Colaiacovo MP. Bisphenol A impairs the double-strand break repair machinery in the germline and causes chromosome abnormalities. Proc Natl Acad Sci U S A 2010;107:20405-10.
27. Polo SE. Reshaping chromatin after DNA damage: the choreography of histone proteins. J Mol Biol 2014;doi: 10.1016/j.jmb.2014.05.025.
28. Xu Y, Ayrapetov MK, Xu C, Gursoy-Yuzugullu O, Hu Y, Price BD. Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-strand break repair. Mol Cell 2012;48:723-33.
29. Xu Y, Sun Y, Jiang X, Ayrapetov MK, Moskwa P, Yang S et al. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J Cell Biol 2010;191:31-43.
30. Ikura T, Tashiro S, Kakino A, Shima H, Jacob N, Amunugama R et al. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol Cell Biol 2007;27:7028-40.
31. Tjeertes JV, Miller KM, Jackson SP. Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J 2009;28:1878-89.
32. Das C, Lucia MS, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009;459:113-7.
33. Bosch-Presegue L, Vaquero A. The dual role of sirtuins in cancer. Genes Cancer 2011;2:648-62.
34. Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A et al. DNA damage, homology-directed repair, and DNA methylation. PLoS Genet 2007;3:e110.
35. Lee GE, Kim JH, Taylor M, Muller MT. DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair. J Biol Chem 2010;285:37630-40.
36. Bernal AJ, Jirtle RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 2010;88:938-44.
37. Li G, Chang H, Xia W, Mao Z, Li Y, Xu S. F0 maternal BPA exposure induced glucose intolerance of F2 generation through DNA methylation change in Gck. Toxicol Lett 2014;228:192-9.
38. Weinhouse C, Anderson OS, Bergin IL, Vandenbergh DJ, Gyekis JP, Dingman MA et al. Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A. Environ Health Perspect 2014;122:485-91.
39. Takagi H, Mitsumori K, Onodera H, Nasu M, Tamura T, Yasuhara K et al. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats. Cancer Lett 2002;178:1-9.
40. Greathouse KL, Bredfeldt T, Everitt JI, Lin K, Berry T, Kannan K et al. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res 2012;10:546-57.
41. Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol 2010;248:111-21.
42. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007;104:13056-61.
43. Dhimolea E, Wadia PR, Murray TJ, Settles ML, Treitman JD, Sonnenschein C et al. Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLoS ONE 2014;9:e99800.
44. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006;66:5624-32.
45. Warita K, Mitsuhashi T, Ohta K, Suzuki S, Hoshi N, Miki T et al. Gene expression of epigenetic regulatory factors related to primary silencing mechanism is less susceptible to lower doses of bisphenol A in embryonic hypothalamic cells. J Toxicol Sci 2013;38:285-9.
46. Collett K, Eide GE, Arnes J, Stefansson IM, Eide J, Braaten A et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin Cancer Res 2006;12:1168-74.
47. Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm Cancer 2010;1:146-55.
48. Bhan A, Hussain I, Ansari KI, Bobzean SA, Perrotti LI, Mandal SS. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol Biol 2014;141:160-70.
49. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.
50. Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, Moen EL et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 2010;29:401-6.